Trial Information

Study for Cervical Intraepithelial Neoplasia Grade 2/3?

Arayvan Clinical Research is seeking volunteers who have been diagnosed with Cervical Intraepithelial Neoplasia Grade 2/3. The purposes of the study is to assess the efficacy of a medication used to treat high grade Cervical Intraepithelial Neoplasia (CIN) grade 2 or 3 associated with High Risk HPV infection.

To see if you are qualified for a clinical study, please contact Arayvan Clinical Research at 817-375-1560/1563, Email: coordinator@arayvan.com, or apply online at www.arayvan.com.
Qualified study participants will receive at no cost:

Study-related medical exams
Investigational study medicine
Free study related laboratory tests at no cost
No Insurance is required. No Co-pay is needed
Compensation for your time and travel

Patient Inclusion Criteria:
You may be eligible to participate if you meet the following inclusion criteria:

18 years of age or older
Have a diagnosis of CIN 2/3
These are just some of the inclusion criteria.

Patient Exclusion Criteria:

The use of any investigational agent(s) for 28 days prior to dosing
Prior biologic therapy or concomitant cancer
A history of listeriosis
Certain illnesses and use of antibiotics
Pregnant women, women actively trying to become pregnant, and nursing women
Allergy to penicillin

There are other criteria that may exclude you from participating. Please call for screening opportunities.

Yolanda Gordon, Recruiting Coordinator
Arayvan Clinical Research
3030 Matlock Road, Suite 202
Arlington, TX 76015
Phone: 817-375-1560/1635
Fax: 480-772-4602
Email: coordinator@arayvan.com

View Map

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:
Message:

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.